Life Science Success

Gregory Glover on Regulatory IP and the Fight for Market Exclusivity

• Don Davis PhD, MBA

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 50:16

Send us Fan Mail

In this episode of the Life Science Success Podcast my guest is Dr. Gregory Glover, founder of the Pharmaceutical Law Group, a Washington, DC practice built at the intersection of FDA regulation and intellectual property.

00:00 Show Introduction
00:29 Meet Gregory Glover
01:15 Doctor to Lawyer Journey
03:00 Why Medical Training Helps
04:07 Hatch-Waxman Origins
08:13 Exclusivity Versus Patents
11:48 Where Hatch-Waxman Ages
14:21 Skinny Label Explained
20:23 Aligning Strategy Early
25:06 Sponsor Break
26:19 When to Start Lifecycle
27:51 What Competitors Can See
29:20 Lifecycle Management Basics
31:29 Manufacturing and Patents
33:22 Overlooked Exclusivity Plays
35:06 BPCIA and Biosimilars
38:09 Policy Misunderstandings
39:27 Who Greg Works With
40:27 Barriers to Maximizing IP
43:07 Funding Climate Effects
45:13 Rapid Fire Reflections
48:51 How to Reach Greg
49:27 Closing and Subscribe

People on this episode

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.